Skip to main content

Fibrocystic Breast Changes

  • Living reference work entry
  • First Online:
Encyclopedia of Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 91 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Reference and Further Reading

  • Bartow, S. A., Black, W. C., Waeckerlin, R. W., & Mettler, F. A. (1982). Fibrocystic disease: A continuing enigma. Pathology Annual, 2, 93–111.

    Google Scholar 

  • Boyd, M., Hildebrandt, R. H., & Bartow, S. A. (1996). Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Research and Treatment, 37, 243–251.

    Article  CAS  Google Scholar 

  • Castells, X., Domingo, L., Corominas, J. M., Torá-Rocamora, I., Quintana, M. J., Baré, M., Vidal, C., Natal, C., Sánchez, M., Saladié, F., Ferrer, J., Vernet, M., Servitja, S., Rodríguez-Arana, A., Roman, M., Espinàs, J. A., & Sala, M. (2015). Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: A study from a population-based screening program. Breast Cancer Research and Treatment, 149, 237–244.

    Article  Google Scholar 

  • Celis, J. E., Gromova, I., Gromov, P., Moreira, J. M., Cabezón, T., Friis, E., & Rank, F. (2006). Molecular pathology of breast apocrine carcinomas: A protein expression signature specific for benign apocrine metaplasia. FEBS Letters, 580, 2935–2944.

    Article  CAS  Google Scholar 

  • Cserni, G. (2012). Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 120, 249–252.

    Article  Google Scholar 

  • Dupont, W. D., & Page, D. L. (1985). Risk factors for breast cancer in women with proliferative breast disease. New England Journal of Medicine, 312, 146–151.

    Article  CAS  Google Scholar 

  • Faiz, O., & Fentiman, I. S. (2000). Management of breast pain. International Journal of Clinical Practice, 54, 228–232.

    CAS  PubMed  Google Scholar 

  • Gromov, P., Espinoza, J. A., & Gromova, I. (2015). Molecular and diagnostic features of apocrine breast lesions. Expert Review of Molecular Diagnostics, 15, 1011–1022.

    Article  CAS  Google Scholar 

  • Hartmann, L. C., Sellers, T. A., Frost, M. H., Lingle, W. L., Degnim, A. C., Ghosh, K., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., Hillman, D. W., Suman, V. J., Johnson, J., Blake, C., Tlsty, T., Vachon, C. M., Melton, L. J., 3rd, & Visscher, D. W. (2005). Benign breast disease and the risk of breast cancer. The New England Journal of Medicine, 353, 229–237.

    Article  CAS  Google Scholar 

  • Hutter, R. V. P., Albores-Saavedra, J., & Anderson, E. et al. (1986). Is ‘fibrocystic disease’ of the breast precancerous? Consensus meeting, New York, October 1985. Archives of Pathology & Laboratory Medicine, 110, 121.

    Google Scholar 

  • Kabat, G. C., Jones, J. G., Olson, N., Negassa, A., Duggan, C., & Ginsberg, M. (2010). A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes and Control, 21, 821–828.

    Article  Google Scholar 

  • Milosevic, Z. C., Nadrljanski, M. M., Milovanovic, Z. M., Gusic, N. Z., Vucicevic, S. S., & Radulovic, O. S. (2017). Breast dynamic contrast enhanced MRI: Fibrocystic changes presenting as a non-mass enhancement mimicking malignancy. Radiology and Oncology, 51, 130–136.

    PubMed  PubMed Central  Google Scholar 

  • Mousavi, S. R., Mousavi, S. M., Samsami, M., & Mahdikhah, Z. (2010). Comparison of tamoxifen with danazol in the management of fibrocystic disease. International Journal of Medicine and Medical Sciences, 2, 329–331.

    CAS  Google Scholar 

  • O’Malley, F. P., & Bane, A. (2008). An update on apocrine lesions of the breast. Histopathology, 52, 3–10.

    Article  Google Scholar 

  • Page, D. L., Vander Zwaag, R., Rogers, L. W., Williams, L. T., Walker, W. E., & Hartmann, W. H. (1978). Relation between component parts of fibrocystic disease complex and breast cancer. Journal of the National Cancer Institute, 61(4), 1055–1063.

    CAS  PubMed  Google Scholar 

  • Parrella, P., Poeta, M. L., Gallo, A. P., Prencipe, M., Scintu, M., Apicella, A., Rossiello, R., Liguoro, G., Seripa, D., Gravina, C., Rabitti, C., Rinaldi, M., Nicol, T., Tommasi, S., Paradiso, A., Schittulli, F., Altomare, V., & Fazio, V. M. (2004). Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clinical Cancer Research, 10, 5349–5354.

    Article  CAS  Google Scholar 

  • Pruthi, S., Wahner-Roedler, D. L., Torkelson, C. J., Cha, S. S., Thicke, L. S., Hazelton, J. H., & Bauer, B. A. (2010). Vitamin E and evening primrose oil for management of cyclical mastalgia: A randomized pilot study. Alternative Medicine Review, 15, 59–67.

    PubMed  Google Scholar 

  • Radi, M. J. (1989). Calcium oxalate crystals in breast biopsies. An overlooked form of microcalcification associated with benign breast disease. Archives of Pathology & Laboratory Medicine, 113(12), 1367–1369.

    CAS  Google Scholar 

  • Shaaban, A. M., Sloane, J. P., West, C. R., Moore, F. R., Jarvis, C., & Williams, E. M. I. (2002). Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. American Journal of Surgical Pathology, 26, 421–430.

    Article  CAS  Google Scholar 

  • Simard, J., Hatton, A. C., Labrie, C., Dauvois, S., Zhao, H. F., Haagensen, D. E., & Labrie, F. (1989). Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells. Molecular Endocrinology, 3, 694–702.

    Article  CAS  Google Scholar 

  • Smith, R. L., Pruthi, S., & Fitzpatrick, L. A. (2004). Evaluation and management of breast pain. Mayo Clinic Proceedings, 79, 353–372.

    Article  Google Scholar 

  • Tavassoli, F. A., & Norris, H. J. (1994). Intraductal apocrine carcinoma: A clinicopathologic study of 37 cases. Modern Pathology, 7, 813–818.

    CAS  PubMed  Google Scholar 

  • Tot, T., Tabàr, L., & Dean, P. B. (2014). Practical breast pathology. Normal breast tissue or fibrocystic change? (pp. 2–23). Stuttgart: Thieme Publishing Group.

    Google Scholar 

  • Tramm, T., Kim, J. Y., & Tavassoli, F. A. (2011). Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast. American Journal of Surgical Pathology, 35, 202–211.

    Article  Google Scholar 

  • Wang, J., Costantino, J. P., Tan-Chiu, E., Wickerham, D. L., Paik, S., & Wolmark, N. (2004). Lower-category benign breast disease and the risk of invasive breast cancer. Journal of the National Cancer Institute, 96, 616–620.

    Article  Google Scholar 

  • Washington, C., Dalbègue, F., Abreo, F., Taubenberger, J. K., & Lichy, J. H. (2000). Loss of heterozygosity in fibrocystic change of the breast: Genetic relationship between benign proliferative lesions and associated carcinomas. American Journal of Pathology, 157, 323–329.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isabella Castellano .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Castellano, I., Metovic, J. (2018). Fibrocystic Breast Changes. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_4707-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_4707-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics